The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns

Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Eric Wooltorton
Publisher: 
Canadian Medical Assocation Journal
Publication Date: 
2006
Publication Place: 
Ottawa, ON

Reviews the Evra patch and the potential for excess estrogen exposure raises concerns about the risks of adverse effects, which include nausea, breast tenderness and venous thromboembolism.

Available From: 
ISBN/ISSN: 
ISSN 0820-3946 (Print)
ISSN 1488-2329 (Online)
Notes: 
Includes bibliographical references.